Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954550 · ClinicalTrials.gov registry record · NA
Effects of Aerobic Exercise for Treating Alzheimer's Disease
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT01954550: Completed NA study, sponsored by University of Minnesota.
NCT01954550 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01954550, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This randomized controlled trial (RCT) will investigate the effects of a 6-month, individualized, moderate-intensity cycling intervention on cognition and hippocampal volume in AD with three aims: * Determine the immediate effect of the cycling intervention on cognition in AD. * Examine if the cycling intervention slows cognitive decline in AD from baseline to 12 months. * Assess the effect of aerobic exercise on hippocampal volume in AD over 12 months using MRI. The investigators will randomize 90 participants to the 6-month cycling or stretching/range of motion exercise (20-50-minute, 3 times a week). Participants will then be followed for another 6 months. Cognition will be assessed at baseline, 3, 6, 9, and 12 months and hippocampal volume will be measured using magnetic resonance imaging (MRI) at baseline, 6, and 12 months.
Primary Outcome
This outcome measure will be given to all study participants.
Interventions
- BEHAVIORAL Cycling exercise
- BEHAVIORAL Range of motion/stretching exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2014-03 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
What the finished NCT01954550 record still lists
NCT01954550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Cycling exercise is the first listed.
NCT01954550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01954550 about?
NCT01954550 is a clinical study titled "Effects of Aerobic Exercise for Treating Alzheimer's Disease". This randomized controlled trial (RCT) will investigate the effects of a 6-month, individualized, moderate-intensity cycling intervention on cognition and hippocampal volume in AD with three aims: * Determine the immediate effect of the cycling intervention on cognition in AD. * Examine if the cycl...
What is the current status of trial NCT01954550?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2014-03. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT01954550?
The interventions under investigation include: Cycling exercise (BEHAVIORAL), Range of motion/stretching exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01954550?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01954550's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia